Vista Pharma inks pact to acquire ANDA for Urocare
Vista Pharmaceuticals has inked a non-disclosure agreement (NDA), to acquire a complex abbreviated new drug application (ANDA) for Urocare. This ANDA will be manufactured at another...
Tag : Vista Pharma
USFDA has issued warning letter to Vista Pharma for Nalgonda unit
The US health regulator USFDA has issued a warning letter to the Hyderabad based Vista Pharmaceuticals over a significant violations of good manufacturing norms at...